Betaxolol CAS 63659-18-7: Leading Manufacturer & Supplier of Cardioselective Beta-1 Adrenergic Blocker
Discover Betaxolol (CAS 63659-18-7), a crucial pharmaceutical intermediate and selective beta-1 adrenergic blocker. Ideal for hypertension and glaucoma treatment. Partner with a trusted manufacturer for high-quality supply.
Get a Quote & SampleUnlock Advanced Pharmaceutical Solutions with Betaxolol
Betaxolol (CAS 63659-18-7)
As a leading manufacturer and supplier in China, we provide high-purity Betaxolol (CAS 63659-18-7). This cardioselective beta-1 adrenergic blocker is vital for pharmaceutical formulations targeting hypertension and glaucoma. We ensure consistent quality and competitive pricing for bulk purchases.
- High Purity Betaxolol for Pharmaceutical Formulations: Our Betaxolol meets stringent quality standards, ensuring optimal therapeutic outcomes.
- Reliable Pharmaceutical Intermediate Supplier: Count on us for a stable supply of this critical API intermediate to meet your production demands.
- Competitive Betaxolol Price in China: Secure cost-effective sourcing for your research and manufacturing needs from our Chinese facility.
- Expertise in Cardiovascular and Ophthalmic APIs: Leverage our deep understanding of Betaxolol's applications in treating hypertension and glaucoma.
Why Choose Our Betaxolol Manufacturer & Supplier
Superior Selectivity and Efficacy
Our Betaxolol is a highly selective beta-1 adrenergic antagonist, minimizing side effects associated with broader beta-blockers, making it ideal for hypertension and glaucoma treatment.
Consistent Quality & Purity
We guarantee a minimum purity of ≥98% (HPLC) for our Betaxolol, ensuring its suitability as a pharmaceutical intermediate and for direct use in research applications.
Global Supply Chain & Support
As a global supplier, we offer flexible packaging, reliable transportation via air or sea, and dedicated customer support for all your Betaxolol purchase inquiries.
Key Applications of Betaxolol
Hypertension Management
Betaxolol is a widely used antihypertensive agent, effectively lowering blood pressure by reducing heart rate and cardiac output.
Glaucoma Treatment
As an ophthalmic drug, Betaxolol reduces intraocular pressure, making it a vital component in treating glaucoma.
Cardioselective Beta-Blocker
Its specific action on beta-1 receptors offers advantages in patients with respiratory conditions, distinguishing it as a preferred choice among beta-blockers.
Pharmaceutical Intermediate
Betaxolol serves as a crucial intermediate in the synthesis of various complex pharmaceutical compounds, supporting advanced drug development.